We propose the present Trpc6-M131T mouse model as a new tool to study the pathogenesis of FSGS caused by Trpc6, to assess the outcomes of drugs treatments and to facilitate studies of Trpc6-related molecular pathways. This evidence concerns the gene TRPC6 and focal segmental glomerulosclerosis.